首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >Design and in vitro evaluation of mucoadhesive mini tablets for nasal drug delivery of sumatriptan
【24h】

Design and in vitro evaluation of mucoadhesive mini tablets for nasal drug delivery of sumatriptan

机译:舒马曲坦鼻腔给药黏膜黏附剂微片的设计与体外评价

获取原文
           

摘要

The aim of the present investigation was to develop Sumatriptan Nasal Mucoadhesive Minitablets using different mucoadhesive polymers Chitosan, Carbopol 971P and Gum copal along with Methocel. Mucoadhesive minitablets of Sumatriptan were prepared by direct compression method. The minitablets were evaluated for thickness, hardness, swelling index, mucoadhesion and in vitro drug release. All postcompressional parameters were found to be within acceptable standard limits. It was observed that mucoadhesive minitablets contained polymer blend of Carbopol, Carbopol/ Chitosan , Carbopol/ Gum copal were successfully controlled the release of drug up to 7 days. The release data were fit into different kinetic models (zero order, first order and Korsemeyer- Peppas powers law equation) the mechanism of drug release was found to follow zero order release. N1 and N6 formulations were selected as optimum formulations based on evaluation studies
机译:本研究的目的是使用不同的粘膜粘附性聚合物壳聚糖,Carbopol 971P和Gum copal以及Methocel开发Sumatriptan鼻粘膜粘附性迷你片剂。通过直接压片法制备舒马曲坦的粘膜粘附小片。评估小型片剂的厚度,硬度,溶胀指数,粘膜粘附性和体外药物释放。发现所有后压缩参数均在可接受的标准范围内。观察到,包含Carbopol,Carbopol /壳聚糖,Carbopol / Gum Copal聚合物共混物的粘膜粘附小片成功地控制了药物的释放长达7天。将释放数据拟合到不同的动力学模型(零阶,一阶和Korsemeyer-Peppas幂定律方程)中,发现药物释放的机理遵循零阶释放。根据评估研究,选择N1和N6配方作为最佳配方

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号